The active efflux of toxic compounds by (multi)drug transporters is one of the mechanisms that bacteria have developed to resist cytotoxic drugs. The authors describe the role of the lactococcal secondary multidrug transporter LmrP in the resistance to a broad range of clinically important antibiotics. Cells expressing LmrP display an increased resistance to the lincosamide, streptogramin, tetracycline and 14-and 15-membered macrolide antibiotics. The streptogramin antibiotic quinupristin, present in the fourth-generation antibiotic RP 59500, can inhibit LmrP-mediated Hoechst 33342 transport, but is not transported by LmrP, indicating that quinupristin acts as a modulator of LmrP activity. LmrP-expressing Lactococcus lactis cells in which a protonmotive force is generated accumulate significantly less tetracycline than control cells without LmrP expression. In contrast, LmrP-expressing and control cells accumulate equal amounts of tetracycline in the absence of metabolic energy. These findings demonstrate that the increased antibiotic resistance in LmrP-expressing cells is a result of the active extrusion of antibiotics from the cell.
INTRODUCTION
The successful introduction of antibiotics in the late 1940s led many to believe that infectious diseases, such as tuberculosis, could be conquered once and for all. The number of multidrug-resistant pathogenic microorganisms, however, demonstrates that microbial antibiotic resistance is a serious threat to public health worldwide (Cohen, 1992 ; Travis, 1994 ; Levy, 1998) . The ease with which bacteria can exchange genetic material plays an important role in the emergence and spread of multidrug resistance (Davies, 1994 ; Baquero & Bla! zquez, 1997 ; Saier et al., 1998 ; Perreten et al., 1997 ; Anderson, 1999) . Therefore, antibiotic resistance genes from pathogenic as well as from non-pathogenic organisms are of medical importance.
One of the sophisticated biochemical mechanisms that bacteria have developed to evade the lethal effects of toxic drugs is the active efflux of these compounds. In contrast to specific drug-efflux systems, multidrug transporters can extrude a wide variety of structurally unrelated compounds. At present, four classes of multidrug efflux systems have been characterized in bacteria : (i) the ATP-binding cassette superfamily, (ii) the major facilitator superfamily, (iii) the resistance-nodulationdivision family, and (iv) the small multidrug resistance family (Paulsen et al., 1996 ; van Veen & Konings, 1998) . Many organisms can express several multidrug transporters belonging to different classes.
In the Gram-positive bacterium Lactococcus lactis at least four drug-extrusion activities have been detected (Molenaar et al., 1992 ; Bolhuis et al., 1994 ; Glaasker et 0002-4799 # 2001 SGM al., 1996 . The PMF-driven extrusion of amphiphilic drugs from the inner leaflet of the membrane is mediated by the multidrug transporter LmrP (Bolhuis et al., 1995 (Bolhuis et al., , 1996 . LmrP is a 408-amino-acid integral membrane protein with 12 putative transmembrane segments, and belongs to the major facilitator superfamily. Extrusion of drugs by LmrP is driven by both the membrane potential and the transmembrane proton gradient, indicating that LmrP mediates an electrogenic proton\ drug antiport reaction (Bolhuis et al., 1996 ; Putman et al., 1999b) .
In this paper we describe the role of the secondary multidrug transporter LmrP in the resistance to a wide range of clinically important antibiotics that are used to fight infectious diseases. LmrP confers resistance to clindamycin, 14-and 15-membered macrolides, dalfopristin, RP 59500 and tetracycline antibiotics. Hence, LmrP and its endogenous and acquired homologues in pathogenic bacteria are a serious threat to the antibioticbased treatment of patients with infectious diseases.
METHODS
Antibiotics. Azithromycin (batch 25381-087-02), ceftazidime (batch UCRZ 2500), ciprofloxacin (batch 530949B\1), clarithromycin (batch 33-132VH), clindamycin (batch 44BXC), gentamicin (batch USQ-6-GMF-N-6029) and meropenem (batch 00047N) were generous gifts from Pfizer, Glaxo Wellcome Research and Development, Bayer, IDC Abbott Laboratories, Pharmacia & Upjohn, Schering-Plough, and Zeneca Pharmaceuticals, respectively. Dalfopristin (batch GRV 1204), quinupristin (batch GRV 1205), RP 59500 (batch CB06274) and spiramycin (batch CA9502600) were gifts from Rho# ne-Poulenc Rorer. Vancomycin (batch X00336 SI05573) was a gift from Eli Lilly & Co. Ofloxacin (batch H900) and roxithromycin (batch 5A 3175B) were gifts from Hoechst Marion Roussel. Ampicillin, chloramphenicol and tetracycline were purchased from Boehringer Mannheim. Chlortetracycline, demeclocycline, erythromycin, kanamycin, minocycline, oxytetracycline and [$H]tetracycline were obtained from Sigma.
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Lactococcus lactis was grown at 30 mC in M17 medium (Difco) supplemented with 0n5 % glucose (w\v) plus 5 µg chloramphenicol ml − " when appropriate. Escherichia coli was grown at 37 mC in Luria Broth containing 50 µg ampicillin ml − " when appropriate.
Preparation of membrane vesicles. L. lactis NZ9000 harbouring the plasmid pHLP5 (Putman et al., 1999a) was grown at 30 mC to an OD ''! of about 0n5. LmrP expression was triggered by the addition of 0n1% (v\v) of the supernatant of the nisin-A-producing L. lactis strain NZ9700, giving a final concentration of approximately 10 ng nisin A ml − ". After incubation for 1 h at 30 mC the cells were harvested by centrifugation. Inside-out membrane vesicles were prepared using a French pressure cell as described by Putman et al. (1999a) . The protein concentration was determined by the Lowry method in the presence of 0n5 % SDS using bovine serum albumin as a standard.
Hoechst 33342 transport. Hoechst 33342 transport mediated by LmrP was studied as described previously (Putman et al., 1999a, b) . Inside-out membrane vesicles (0n5 mg protein ml − ") were resuspended in 50 mM potassium HEPES, pH 7n0, containing 2 mM MgSO % , 8n5 mM NaCl, 0n1 mg creatine kinase ml − ", plus 5 mM phosphocreatine. After 30 s incubation at 30 mC Hoechst 33342 was added to 1 µM final concentration. LmrP was energized by the generation of a proton-motive force (PMF) by the F ! F " H + -ATPase, upon the addition of 0n5 mM Mg# + -ATP. The amount of membraneassociated Hoechst 33342 was measured fluorimetrically (Perkin Elmer LS50B fluorometer), using excitation and emission wavelengths of 355 and 457 nm, respectively, and slit widths of 5 nm each. The initial rate of Hoechst 33342 transport was determined by linear regression of the fluorescence data obtained in the first 15 s after Mg# + -ATP addition.
Measurement of the transmembrane H
M gradient (∆pH) in membrane vesicles. The ∆pH (inside acid) in inside-out membrane vesicles was monitored by fluorescence quenching of acridine orange as described previously (Putman et al., 1999a) . The transmembrane potential (∆ψ, inside positive) in inside-out membrane vesicles was estimated from the increase in ∆pH upon dissipation of the ∆ψ by the addition of the K + ionophore valinomycin. To study the effect of antibiotics on the PMF, the drugs were added to a final concentration of 1 and 4 times the IC &! for inhibition of LmrP-mediated Hoechst 33342 transport.
Determination of growth rate. For the determination of growth rates in the presence of various antibiotics, overnight E. coli cultures (DH5α\pET302 and DH5α\pHLP1) were diluted into fresh medium and grown to mid-exponential phase. The cells were then diluted in fresh medium to an OD ''! of 0n025 and 150 µl aliquots of the cell suspension were transferred to sterile low-protein-binding 96-well microplates (Greiner), containing 50 µl of various concentrations of the antibiotics in fresh medium. For the induction of LmrP expression isopropyl 1-thio-β--galactopyranoside was added to a final concentration of 5 µM. Aliquots (50 µl) of sterile silicone oil were pipetted on top of the sample to prevent evaporation. The cells were grown semi-anaerobically at 30 mC, and the cell density was monitored by measuring the absorbance at 690 nm every 15 min for 23 h in a multiscan photometer (Titretek Multiscan MCC\340 MKII). Growth rates were determined by non-linear least-square fitting of the absorbance data to the Gompertz equation describing bacterial growth (Zwietering et al., 1990) . The antibiotic concentrations which inhibited the growth rate by 50 % (IC &! ) were determined.
Tetracycline accumulation in whole cells. L. lactis NZ9000 cells harbouring the control plasmid (pNZ8048) or the LmrPexpression plasmid (pHLP5) were grown at 30 mC to midexponential phase (OD ''! 0n5). Nisin A was added to a concentration of approximately 10 ng ml − ", to trigger the transcription of the lmrP gene. Subsequently, the cells were incubated for 1 h at 30 mC, harvested by centrifugation, washed three times in 50 mM potassium phosphate, pH 7n0, containing 0n2 % glucose and 1 mM MgSO % , and resuspended in the same buffer to a protein concentration of approximately 0n75 mg ml − ". After a 10 min preincubation of 100 µl aliquots of the cell suspension at 30 mC, [$H]tetracycline was added to a final concentration of 5 µM. At the time points indicated in the legend to Fig. 4 , the reaction was stopped by the addition of 2 ml ice-cold 100 mM potassium phosphate, pH 7n0, containing 100 mM LiCl. The samples were rapidly filtered through 0n45 µm pore-size cellulose acetate filters (Schleicher & Schuell). The filters were washed once with 2 ml ice-cold Bolhuis et al. (1996) 100 mM potassium phosphate, pH 7n0, plus 100 mM LiCl. The radioactivity on the filters was determined by liquid scintillation counting.
RESULTS

Inhibition of LmrP-mediated drug transport
To study the specificity of antibiotic binding to LmrP, several classes of clinically important antibiotics were tested for their ability to inhibit the LmrP-mediated transport of Hoechst 33342. The bisbenzimide dye Hoechst 33342 is fluorescent in a lipid environment, but Relative initial rate essentially non-fluorescent in aqueous solution. Therefore, the LmrP-mediated transport of Hoechst 33342 from the membrane into the lumen of inside-out membrane vesicles of L. lactis can be monitored as a loss of fluorescence in time (Fig. 1a) . Antibiotics that are substrates of LmrP compete with Hoechst 33342 for binding to LmrP, and consequently inhibit Hoechst 33342 transport. A typical result, obtained with azithromycin, is shown in Fig. 1(a) . From the dose-response curve (Fig. 1b) the concentration giving 50 % inhibition of the initial rate of LmrP-mediated Hoechst 33342 transport (IC &! ) was determined for the various anti- that these antibiotics do not bind to LmrP. Lincosamide, macrolide and streptogramin antibiotics significantly inhibited LmrP-mediated Hoechst 33342 transport ( Table 2 ).
The antibiotics could inhibit the Hoechst 33342 transport by a direct interaction with LmrP or by interfering with the driving force for LmrP-mediated transport. To analyse the effect of the antibiotics on the PMF, the fluorescent probe acridine orange was used (Fig. 2) . Generation of a ∆pH (inside acid) causes quenching of acridine orange fluorescence. Upon addition of valinomycin, the fluorescence further decreases, due to the interconversion of ∆ψ into ∆pH. The subsequent dissipation of the pH gradient, by the addition of nigericin, leads to the release of acridine orange from the vesicles, with a concomitant increase in fluorescence (Ramaswamy et al., 1989) . This increase is indicative of the magnitude of the PMF that was generated. The acridine orange measurements revealed that azithromycin, clarithromycin, erythromycin, roxithromycin, dalfopristin and quinupristin, at concentrations of up to 4 times their IC &! , did not significantly affect the magnitude and composition of the PMF. However, as shown in Fig. 2 , clindamycin and spiramycin inhibited the generation of a PMF in the inside-out membrane vesicles at a concentration equal to their respective IC &! . These results indicate that clindamycin and spiramycin inhibit LmrP-mediated Hoechst 33342 transport indirectly by interfering with the generation of the driving force for transport, whereas the other macrolide and streptogramin antibiotics interact with LmrP directly. 
Antibiotic transport by LmrP
The antibiotic specificity of LmrP was further studied in cytotoxicity assays. This type of experiment allowed the use of antibiotics which interfered with Hoechst 33342 fluorescence in the previous experiment. In cytotoxicity assays, the antibiotic susceptibilities of cells overexpressing the drug transporter are compared with those of non-LmrP-expressing control cells. Unfortunately, previous work showed that the overexpression of LmrP is detrimental to the cells (Putman et al., 1999a) . A positive effect of LmrP on antibiotic resistance is hard to interpret against a background of growth inhibition by LmrP expression. Therefore the experiments were performed in E. coli cells with a low level of LmrP expression (DH5α\pHLP1, induced with 5 µM IPTG), which have a growth rate comparable to that of the control cells (DH5α\pET302). The growth rates of DH5α\pET302 and DH5α\pHLP1 were determined in the presence of a variety of antibiotics. A typical result, obtained with erythromycin, is shown in Fig. 3 . The dose-response curve of the LmrPexpressing cells is shifted towards higher erythromycin concentrations, compared to the curve of the control cells, indicating that LmrP increases the resistance to this antibiotic, even at this low level of expression of LmrP. The concentration of the various antibiotics required to inhibit the growth rate by 50 % (IC &! ) is shown in Table 3 . Because of the presence of an ampicillin-resistance marker on plasmids pET302 and pHLP1, ampicillin was not included in the cytotoxicity experiments. Since the sulfonamide antibiotic sulfamethoxazol did not significantly inhibit E. coli growth at a concentration of 400 µg ml −" (data not shown), this compound was omitted from further studies.
Comparison of the IC
&! values for DH5α\pHLP1 and DH5α\pET302 revealed that the observed differences between the LmrP-expressing and control cells are small. This is due to the very low level of LmrP expression under the conditions used. Only for lincosamides, tetracyclines and a number of macrolide and streptogramin antibiotics was a shift in the dose-response curve (Fig. 3) observed in each single measurement. Although after averaging the measurements some of the data (Table 3 ) actually overlap in their standard deviation, we consider these antibiotics to be substrates for LmrP. LmrP consistently increased the resistance to the macrolides azithromycin, clarithromycin, erythromycin and roxithromycin. These macrolide antibiotics contain a 14-or 15-membered lactone ring that has one or more deoxysugars attached (Woodward, 1957 ; Ballow & Amsden, 1992) . Interestingly, LmrP did not seem to confer resistance to the 16-membered macrolide spiramycin. LmrP expression increased the resistance to the streptogramins dalfopristin and RP 59500, but did not affect the resistance to quinupristin. The fourthgeneration antibiotic RP 59500 is a combination of dalfopristin and quinupristin, which demonstrates synergistic and bactericidal activity against pathogens including methicillin-resistant Staphylococcus aureus (Leclerq & Courvalin, 1991 ; Aumercier et al., 1992 ; Kang & Ryback, 1995) . The LmrP-expressing strain showed higher resistance to all tetracycline antibiotics tested, indicating that substitutions on carbon atoms 5, 6 and 7 do not preclude the interaction between LmrP and the tetracycline antibiotics. LmrP expression did not increase the resistance to aminoglycosides, β-lactams, glycopeptides, quinolones, and chloramphenicol.
Electrogenic tetracycline transport by LmrP
To determine whether the observed resistance to tetracycline antibiotics in LmrP-expressing cells is indeed caused by an active extrusion process, the accumulation of tetracycline in LmrP-expressing and control L. lactis cells was measured. In the presence of an energy source the control cells (NZ9000\pNZ8048) accumulated sixfold more tetracycline than the LmrP-expressing NZ9000\pHLP5 cells (Fig. 4a) . Dissipation of the membrane potential by the addition of valinomycin (Fig. 4b) resulted in a slight increase in the amount of tetracycline in the control cells. This is most likely due to an increase in ∆pH, which is a driving force for the passive influx of tetracycline into the cell (Munske et al., 1984) . The accumulation of tetracycline in the LmrPexpressing cells was hardly affected by the addition of valinomycin, indicating that the ∆pH is a driving force for LmrP-mediated tetracycline extrusion. Dissipation of the ∆pH by the addition of nigericin slightly reduced the high level of tetracycline accumulation in control cells, but did not affect the low level of tetracycline accumulation in LmrP-expressing cells (Fig. 4c) . When both components of the PMF were dissipated by the addition of both valinomycin and nigericin (Fig. 4d) , equal tetracycline accumulation in both the control and LmrP-expressing cells was observed. These results demonstrate that the increased tetracycline resistance in LmrP-expressing cells is a result of the active extrusion of tetracycline by LmrP. Both the ∆pH and ∆ψ can drive the LmrP-mediated tetracycline efflux, indicative of an electrogenic tetracycline\H + antiport reaction.
DISCUSSION
Despite the very low level of expression of LmrP in the cytotoxicity experiments, a consistently increased resistance to four classes of antibiotics was observed. The involvement of LmrP in the resistance to these compounds is supported by the inhibition of LmrP-mediated Hoechst 33342 transport by macrolide and streptogramin antibiotics, and the active transport of tetracycline by LmrP. Altogether, these results indicate that the antibiotic specificity of LmrP includes lincosamides, 14-and 15-membered macrolides, streptogramins and the tetracycline class of antibiotics. Unlike other secondary multidrug transporters, such as AcrAB, Bmr, MdfA, MexAB, NorA, NorM and Tap, LmrP did not confer resistance to aminoglycosides, β-lactam antibiotics, quinolones or chloramphenicol (Yoshida et al., 1990 ; Neyfakh, 1992 ; Li et al., 1995 ; Edgar & Bibi, 1997 ; Aı! nsa et al., 1998 ; Morita et al., 1998 ; . Although macrolides, lincosamides and streptogramins differ structurally, these antibiotics are often grouped together (MLS antibiotics) because of their similar mechanism of action, which involves the inhibition of protein synthesis through the binding to the 50S subunit of the bacterial ribosome (Contreras & Va! squez, 1977) . Although the most widespread mechanism of resistance to MLS-type antibiotics is target-site alteration (Weisblum, 1995) , this work and other studies (Leclerq & Courvalin, 1991 ; Clancy et al., 1996) demonstrate that the resistance to MLS-type antibiotics can also result from enhanced antibiotic efflux. LmrP confers resistance only to the 14-and 15-membered macrolides. The macrolide specificity of LmrP resembles that of the multidrug transporter MefA from Streptococcus pyogenes, which confers resistance to 14-and 15-but not to 16-membered macrolide antibiotics (Clancy et al., LmrP-mediated antibiotic resistance 1996) . LmrP expression increased the resistance to dalfopristin and RP 59500, but not to quinupristin, suggesting that quinupristin is not transported by LmrP. However, the observed inhibition of LmrP-mediated Hoechst 33342 transport by quinupristin demonstrated that this streptogramin can bind to LmrP. The ability of quinupristin to modulate the activity of multidrug efflux systems may be one of the mechanisms responsible for the synergistic activity of the combination of dalfopristin and quinupristin in antibiotic-based therapy.
Cells expressing LmrP showed an increased resistance to the tetracycline antibiotics. Studies with radio-labelled tetracycline demonstrated that LmrP-expressing cells accumulate significantly less tetracycline than control cells, indicating that the increased tetracycline resistance is due to the active extrusion of tetracycline by LmrP. Dissipation of the ∆pH or ∆ψ only did not increase the accumulation of tetracycline in the LmrP-expressing cells, suggesting that the LmrP-mediated transport of tetracycline is an electrogenic process. This observation is similar to previous observations on the LmrPmediated transport of TPP + (Bolhuis et al., 1996) and Hoechst 33342 (Putman et al., 1999b) and the TetLmediated transport of tetracycline (Guffanti & Krulwich, 1995) . Specific tetracycline transporters, such as TetB of E. coli and TetL of Bacillus subtilis, extrude a complex of tetracycline and a divalent cation in an exchange with one (TetB ; Yamaguchi et al., 1990 Yamaguchi et al., , 1991 or more protons (TetL ; Guffanti & Krulwich, 1995) . The role of divalent cations in the LmrP-mediated tetracycline transport will be a subject of further research.
The antibiotic specificity of LmrP indicates that PMFdependent multidrug transporters can affect the efficacy of a number of clinically relevant antibiotics. Although L. lactis is occasionally found as a pathogen in immunocompromised hosts, this bacterium is generally considered to be non-pathogenic and safe to use in starter cultures for cheese production (Gasser, 1994) . Given the broad antibiotic specificity of the lactococcal secondary multidrug transporter LmrP and the ATP-binding cassette transporter LmrA (Putman et al., 2000) , additional studies are required to determine the probability of transfer of chromosomal resistance genes, such as lmrA and lmrP, to other bacteria in food or the digestive tract.
